Data2Discovery Inc

Biotech · Private

Informatics software platform for data integration and analysis in pharmaceutical drug discovery using semantic graph technologies

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026

Sector: Biotech
Total capital: $1.6M

Federal grants: $1.5M; 2 awards · 2015–2017; Rank in peer group#8 of 20
Private capital raised: None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts: $97K; 3 awards · Health and Human S; Rank in Biotech#333 of 4373
Granted patents: 0; 4 pending

Capital timeline

Latest events

Mar 2017Federal grantNSF · Phase II · SBIR Phase II: Semantic Link Association Prediction for Phenotypic Drug Discovery$1.3M
Feb 2016Federal contractHealth and Human S · Igf::ot::igf$48K
Dec 2015Federal grantNSF · Phase I · SBIR Phase I: Semantic Link Association Prediction for Phenotypic Drug Discovery$180K
Jan 2015Federal contractHealth and Human S · Igf::ot::igf$25K
Sep 2014Federal contractHealth and Human S · Analysis Of Npc PD2 Data Igf::ot::igf$25K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 20 peers

Line = median

Biotech · Software

Federal grants#8 · top 40%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 0 granted of 4

Apr 2, 2026PendingCompositions And Methods For Treating Mycobacterium InfectionsUSPTOApplication 19113756
PendingCompositions And Methods For Treating Mycobacterium InfectionsUSPTOApplication PCTUS2023033252
PendingCompositions And Methods For Treating Mycobacterium InfectionsUSPTOApplication 63408677

Show all 4 patent records

Compositions And Methods For Treating Mycobacterium InfectionsApr 2, 2026 · Application 19113756Pending
Compositions And Methods For Treating Mycobacterium InfectionsApplication PCTUS2023033252Pending
Compositions And Methods For Treating Mycobacterium InfectionsApplication 63408677Pending
Object Oriented System And Method Having Semantic Substructures For Machine LearningApplication 62299310Pending

SYNZYME TECHNOLOGIES LLCSimilar federal contract value in Biotech · $100K in contracts
B-MoGen Biotechnologies IncSimilar federal contract value in Biotech · $100K in contracts
ADVAITA CORPSimilar federal contract value in Biotech · $97K in contracts
FLUENT BIOSCIENCES INCSimilar federal contract value in Biotech · $96K in contracts
Bellbrook Labs, LLCSimilar federal contract value in Biotech · $90K in contracts
FINA BIOSOLUTIONS LLCSimilar federal contract value in Biotech · $83K in contracts

Regulatory activity · Biotech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.